These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3943193

  • 21. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [Abstract] [Full Text] [Related]

  • 22. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S, Kitagawa M, Morimoto S, Miyazaki Y, Minakata S, Yasukawa S, Fukatani T, Ohkawa T.
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [Abstract] [Full Text] [Related]

  • 23. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A.
    Clin Chim Acta; 1995 Jul 31; 239(1):1-11. PubMed ID: 7586581
    [Abstract] [Full Text] [Related]

  • 24. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr 31; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 25. Calcium oxalate urinary calculi: clinical and chemical aspects.
    Elliot JS.
    Medicine (Baltimore); 1983 Jan 31; 62(1):36-43. PubMed ID: 6823212
    [Abstract] [Full Text] [Related]

  • 26. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M, Roux JO, Bourelly F, Boularan AM, Guiter J, Monnier L.
    Br J Urol; 1994 Sep 31; 74(3):294-7. PubMed ID: 7953257
    [Abstract] [Full Text] [Related]

  • 27. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP.
    Br J Urol; 1991 Nov 31; 68(5):454-8. PubMed ID: 1747716
    [Abstract] [Full Text] [Related]

  • 28. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Okawa T.
    Hinyokika Kiyo; 1986 Dec 31; 32(12):1773-9. PubMed ID: 3825824
    [Abstract] [Full Text] [Related]

  • 29. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar 31; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 30. Oxalate transport and calcium oxalate renal stone disease.
    Verkoelen CF, Romijn JC.
    Urol Res; 1996 Mar 31; 24(4):183-91. PubMed ID: 8873376
    [Abstract] [Full Text] [Related]

  • 31. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P, Nemat S, Rose GA.
    Urol Res; 1990 Mar 31; 18(6):393-6. PubMed ID: 2100414
    [Abstract] [Full Text] [Related]

  • 32. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M.
    Urol Int; 2003 Mar 31; 70(4):273-7. PubMed ID: 12740490
    [Abstract] [Full Text] [Related]

  • 33. [Studies on oxalate in urolithiasis. III. Effect of xylitol infusion on plasma and urinary oxalate (author's transl)].
    Ogawa Y.
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec 31; 72(12):1553-8. PubMed ID: 7345193
    [No Abstract] [Full Text] [Related]

  • 34. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S, Hesse A, Zimmermann DJ, Sauerbruch T, von Unruh GE.
    J Urol; 2006 May 31; 175(5):1711-5. PubMed ID: 16600737
    [Abstract] [Full Text] [Related]

  • 35. An investigation into the role of ascorbic acid in renal calculogenesis in albino rats.
    Singh PP, Sharma DC, Rathore V, Surana SS.
    J Urol; 1988 Jan 31; 139(1):156-7. PubMed ID: 3336088
    [Abstract] [Full Text] [Related]

  • 36. Risk factors in calcium stone disease of the urinary tract.
    Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB.
    Br J Urol; 1978 Dec 31; 50(7):449-54. PubMed ID: 37975
    [Abstract] [Full Text] [Related]

  • 37. The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion.
    Tiselius HG, Almgård LE.
    Eur Urol; 1977 Dec 31; 3(1):41-6. PubMed ID: 556987
    [Abstract] [Full Text] [Related]

  • 38. Transmembrane oxalate exchange: its relationship to idiopathic calcium oxalate nephrolithiasis.
    Motola JA, Urivetsky M, Molia L, Smith AD.
    J Urol; 1992 Mar 31; 147(3):549-52. PubMed ID: 1538426
    [Abstract] [Full Text] [Related]

  • 39. Comparison of urinary oxalate excretion in urolithiasis patients with and without hypercalciuria.
    Koide T, Bowyer RC, Brockis JG.
    Br J Urol; 1985 Oct 31; 57(5):505-9. PubMed ID: 4063729
    [Abstract] [Full Text] [Related]

  • 40. Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controls.
    Oehlschläger S, Fuessel S, Meye A, Herrmann J, Lotzkat U, Froehner M, Albrecht S, Wirth MP.
    Urology; 2011 Jan 31; 77(1):250.e1-5. PubMed ID: 20947140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.